WASHINGTON — Federal health advisers on Wednesday endorsed a blood test designed to spot signs of various cancers in apparently healthy people while warning that it’s far from clear how well the technology works. Grail Inc.’s Galleri test doesn’t diagnose cancer but instead, with a single blood draw, looks for a signal that someone may
A key advisory committee that reviews medical devices for the Food and Drug Administration will meet today to vote on whether the agency should approve the first multi-cancer blood test. Grail, the company that makes the Galleri blood test under review, says it can detect up to 50 forms of cancer, many of which are
This summer, every meal feels like a risk. Just as the US is recovering from a major cyclospora outbreak stemming from tainted iceberg lettuce, salmonella has turned up in jalapeños, eggs, and even dog food. The jalapeño-related outbreak is now responsible for at least 431 illnesses and 57 hospitalizations in more than two dozen states.
Trump has praised Overton, a former general surgery resident at Johns Hopkins University School of Medicine and chief policy officer at conservative think tank America First Policy Institute, as a “rockstar” future leader of the FDA. But her nomination to the top job comes at a time where Trump officials are attempting to take steps
FILE – A sign for the U.S. Food and Drug Administration is displayed outside their offices in Silver Spring, Md., Dec. 10, 2020. (AP Photo/Manuel Balce Ceneta, File) Manuel Balce Ceneta/AP hide caption toggle caption Manuel Balce Ceneta/AP The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering
The Food and Drug Administration on Wednesday approved Rasonque, a once-daily pill developed by Revolution Medicines to block several forms of the RAS protein — the mutation that drives tumor growth in most pancreatic cancers, and in roughly a quarter of all human cancers overall. For investors like Dr. Danish Nagda, an early shareholder in
